Skip to main content
ACG 2024 Annual Meeting Main banner
Icon Legend
This session is not in your Favorites.
This session is in your Favorites. Click again to remove it.
Presentation Icons
ACG Award Winner
ACG Award Winner
ACG Newsworthy Abstract
ACG Newsworthy Abstract
Registration Required
Registration Required
No CME
No CME
On-Demand Video
On-Demand Video
Livestream
Livestream
Back

Yinghong Wang, MD, MSc, PhD

Professor
University of Texas MD Anderson Cancer Center
Houston, TX

Yinghong Wang, MD, MSc, PhD, has a strong academic background and profound clinical experience from world renowned medical programs (Johns Hopkins, Cleveland Clinic). She has broad research collaboration network worldwide and holds more than 140 peer-reviewed publications and numerous international conference presentations in her academic career. Dr. Wang’s specialized areas include Inflammatory Bowel Disease (IBD), fecal microbiota transplantation (FMT), and cancer immunotherapy induced gastrointestinal toxicities. She has been recognized internationally for her expertise in managing cancer immunotherapy induced GI toxicities and fecal microbiota transplantation. She is taking a leading role on the management of immunotherapy related toxicity and serves as the chair of institutional immunotherapy toxicity working group, and panel members on all the oncology and GI societies for toxicity guidelines (ASCO, NCCN, SITC, ESMO, AGA, ACG). Dr. Wang spearheaded pioneering work of applying fecal transplantation to treat immunotherapy-induced colitis with high efficacy and elucidated unique microbiome signature and immune profiles. Numerous multi-center studies that she organized led to dramatical changes in the standard management for oncology-related GI toxicity.

Presentation(s):

Email Yinghong